Topic - Purdue Pharma

Purdue Pharma L.P., is a privately-held pharmaceutical company founded by physicians and now located in Stamford, Connecticut. In its early years, Purdue was known for its antiseptic product, Betadine Solution, and its Senokot laxatives. Today, it is best known for its pain-treatment products, MS Contin Tablets and OxyContin Tablets, but it has also branched into other areas such as oncology and nutraceuticals. - Source: Wikipedia

Related Stories

Justice Dept. files complaint against CVS for facilitating unlawful sale of prescription opioids

By Steve LeBlanc - Associated Press

Protesters gather outside a courthouse on Friday, Aug. 2, 2019, in Boston, where a judge was to hear arguments in Massachusetts' lawsuit against Purdue Pharma over its role in the national drug epidemic. (AP Photo/Charles Krupa, File)

McKinsey & Company agrees to pay $650 million to settle federal probe over opioids work

By Geoff Mulvihill and Alanna Durkin Richer - Associated Press

Supreme Court’s Purdue Pharma ruling gives ammunition to victims in bankruptcy cases

By Alex Swoyer - The Washington Times

A close up of a Boy Scout uniform is photographed on Feb. 4, 2013, in Irving, Texas. On Tuesday, March 28, 2023, a federal district court judge upheld the approval of a $2.4 billion bankruptcy reorganization plan aimed at resolving tens of thousands of child sexual abuse claim against the Boy Scouts of America. (AP Photo/Tony Gutierrez, File)

Supreme Court asked to pause Boy Scouts of America $2.46B bankruptcy settlement

By Alex Swoyer - The Washington Times

The U.S. Supreme Court is seen before sunrise on Capitol Hill in Washington, March. 21, 2022. On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.(AP Photo/Jose Luis Magana) **FILE**

OxyContin maker bankruptcy deal goes before the Supreme Court on Monday, with billions at stake

By Mark Sherman - Associated Press

The U.S. Supreme Court is seen before sunrise on Capitol Hill in Washington, March. 21, 2022. On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.(AP Photo/Jose Luis Magana) **FILE**

Supreme Court struggles with feds’ objection to Purdue Pharma bankruptcy deal

By Alex Swoyer - The Washington Times

The U.S. Supreme Court is seen before sunrise on Capitol Hill in Washington, March. 21, 2022. On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.(AP Photo/Jose Luis Magana) **FILE**

WATCH: Supreme Court wrestles with OxyContin maker’s bankruptcy deal

By Mark Sherman - Associated Press

Ellen Isaacs, left, and Lee Nuss, center, both from Florida, hold each other and sing a song of remembrance for Randall M. Nuss, Lee's husband, during a protest with other advocates for opioid victims outside the U.S. Department of Justice, Dec. 3, 2021, in Washington. Families who lost loved ones to overdose are divided over OxyContin maker Purdue Pharma's plan to settle lawsuits over the toll of opioids with governments. It could provide billions to address an overdose epidemic and pay some victims. But it would also protect members of the Sackler family who own the company from future lawsuits. (AP Photo/Carolyn Kaster) **FILE**

Purdue Pharma bankruptcy in limbo as Supreme Court prepares to hear arguments

By Alex Swoyer - The Washington Times

The U.S. Supreme Court is seen on Thursday, July 13, 2023, in Washington. (AP Photo/Mariam Zuhaib)

Supreme Court blocks OxyContin maker’s bankruptcy deal that would shield Sackler family members

Associated Press

Court says OxyContin maker’s bankruptcy and protections for Sackler family members can move ahead

By Geoff Mulvihill - Associated Press

In this image from video provided by C-SPAN, Louis Milione, the U.S. Drug Enforcement Administration's deputy administrator, speaks during a hearing held by the House Energy and Commerce Subcommittee on Health in Washington on Dec. 2, 2021. Milione, the DEA’s second-in-command, quietly resigned in 2023, amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma. (C-SPAN via AP, File)

Revolving door: DEA’s No. 2 quits amid reports of previous consulting work for Big Pharma

By Joshua Goodman and Jim Mustian - Associated Press

Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., on Aug. 9, 2021. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York on Tuesday, May 30, overturned a lower court’s 2021 ruling that found bankruptcy courts did not have the authority to protect members of the Sackler family who own the company and who have not filed for bankruptcy protection from lawsuits. (AP Photo/Seth Wenig, File)

Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits

By Geoff Mulvihill - Associated Press

FILE - In this Feb. 19, 2019, file photo, West Virginia Attorney General Patrick Morrisey speaks at a news conference in Martinsburg, W.Va. Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set to begin in a seven-week trial over the opioid epidemic, Attorney General Patrick Morrisey said Wednesday, May 25, 2022. (Matthew Umstead/The Herald-Mail via AP, File)

Tentative $161.5 million settlement reached in opioid trial

By John Raby - Associated Press

Lynn Wencus of Wrentham, Mass., holds a sign for her son Jeff along with wearing a sign showing loved ones lost to OxyContin and Opioid overdoses, during a protest at Purdue Pharma headquarters in Stamford, Conn., Friday, Aug. 17, 2018. Wencus lost her son Jeff to a heroin overdose in 2017. OxyContin maker Purdue Pharma and virtually all U.S. states have agreed to a new settlement of opioid lawsuits. The deal reached Thursday, March 3, 2022, would require members of the Sackler family who own the drugmaker to pay $5.5 billion to $6 billion in cash. They also apologized. A bankruptcy judge must still approve the deal. (AP Photo/Jessica Hill, File)

Purdue Pharma deal has families deflated, angry but hopeful

By John Seewer and Dave Collins - Associated Press

Fake pill bottles with messages about OxyContin maker Purdue Pharma are displayed during a protest outside the courthouse where the bankruptcy of the company is taking place in White Plains, N.Y., on Aug. 9, 2021. A judge said he is extending legal protections for members of the Sackler family, Wednesday, March 2, 2022, who own OxyContin maker Purdue Pharma by another three weeks to buy time to work out a new settlement to thousands of lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)

Purdue Pharma, U.S. states agree to new opioid settlement

By Geoff Mulvihill and John Seewer - Associated Press